<DOC>
	<DOCNO>NCT00292292</DOCNO>
	<brief_summary>The Kineflex Spinal System bad Charite Spinal System patient single level degenerative disc disease L4/5 L5/S1 .</brief_summary>
	<brief_title>Kineflex Artificial Disc System Treat Degenerative Disc Disease ( DDD )</brief_title>
	<detailed_description>The Kineflex disc 3-piece modular design consist 2 cobalt chrome molybdenum ( CCM ) end-plates fully articulating CCM core . The system available 3 foot print size .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Inclusion Criteria Summary : Be 18 60 year age Have evidence degenerative disc disease ( DDD ) History back and/or radicular pain severe , ongoing recurrent Minimum 6 month period prior conservative care Moderate Oswestry Disability Index score Moderate pain score Be likely return followup visit Be willing able provide Informed Consent study participation . Exclusion Criteria Summary : Any back leg pain unknown origin Foot drop Previous trauma study treatment level compression burst Previous retroperitoneal surgery Other spinal surgery affect level except IDET , laminotomy Previous thoracic lumbar fusion Documented abnormal abdominal vessel muscular/fascial pathology morphology Degenerative spondylolisthesis Ischemic ( spondylolytic ) spondylolisthesis Spondylitis Documented significant spinal , foraminal lateral stenosis Severely reduce disc space height Documented presence free nuclear fragment Extensive facet arthritis degeneration facet level noted MRI , CT Xray Scoliosis lumbar spine Metabolic bone disease Active systemic infection Hepatitis Active malignancy history metastatic malignancy Any terminal autoimmune disease Any disease , condition surgery might impair heal Recent history chemical alcohol dependence Current extend use drug know interfere bone soft tissue heal Known metal allergy Morbid obesity Transitional vertebra level treat clearly fuse Currently prisoner Currently involve spinal litigation Currently experience episode major mental illness Pregnancy time enrollment , since would contraindicate abdominal surgery Participation another drug , diologic medical trial within 30 day study surgery Lives 300 mile study center participation investigational drug , biologic medical device study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>